Cognitive performance and brain volume among survivors of pediatric hematological malignancies: a case-control study.
Amira M OsmanAmany M AliHeba A SayedHaisam AttaShimaa AhmedNelly AlieldinMohamed A AbdelhamedKhaled SaadAzza ShiblPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Hematological malignancies have a negative impact on cognition. Neurocognitive impairment and related brain changes were evident in those who received RTH, HDMTX, or high cumulative doses of steroids.